Baijin Life Science Unit Sets Framework Deal to Grow Medical Business; Shares Lose 2%

MT Newswires Live

Dec 02

Baijin Life Science (HKG:1466) said its unit, Beijing Baijin Biotechnology, signed a cooperation framework agreement with Shanghai Guhuan Medical Equipment to support the expansion of its medical products business, according to a Monday Hong Kong bourse filing.

Shares of the company were down nearly 2% in Tuesday morning trade.

Under the framework, Beijing Baijin plans to invest in Guhuan Medical through an equity subscription and work with the company to develop branded medical product sales channels for Baijin's self-operated stores.

The agreement runs through Dec. 31, 2026, and may be terminated by either party with 10 days' notice.

Guhuan Medical has operated in the medical-product supply chain for more than a decade and holds stakes in over 30 medical cosmetic institutions, the filing said.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2588083699"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2588083699\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2588083699?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-02 11:01","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2588083699","market":"sh","top_or_hot":-1,"title":"Baijin Life Science Unit Sets Framework Deal to Grow Medical Business; Shares Lose 2%","media":"MT Newswires Live","content":"<html><body><p> Baijin Life Science (HKG:1466) said its unit, Beijing Baijin Biotechnology, signed a cooperation framework agreement with Shanghai Guhuan Medical Equipment to support the expansion of its medical products business, according to a Monday Hong Kong bourse filing.</p><p>Shares of the company were down nearly 2% in Tuesday morning trade.</p><p>Under the framework, Beijing Baijin plans to invest in Guhuan Medical through an equity subscription and work with the company to develop branded medical product sales channels for Baijin's self-operated stores.</p><p>The agreement runs through Dec. 31, 2026, and may be terminated by either party with 10 days' notice.</p><p>Guhuan Medical has operated in the medical-product supply chain for more than a decade and holds stakes in over 30 medical cosmetic institutions, the filing said.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Baijin Life Science Unit Sets Framework Deal to Grow Medical Business; Shares Lose 2%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBaijin Life Science Unit Sets Framework Deal to Grow Medical Business; Shares Lose 2%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-12-02 11:01</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Baijin Life Science (HKG:1466) said its unit, Beijing Baijin Biotechnology, signed a cooperation framework agreement with Shanghai Guhuan Medical Equipment to support the expansion of its medical products business, according to a Monday Hong Kong bourse filing.</p><p>Shares of the company were down nearly 2% in Tuesday morning trade.</p><p>Under the framework, Beijing Baijin plans to invest in Guhuan Medical through an equity subscription and work with the company to develop branded medical product sales channels for Baijin's self-operated stores.</p><p>The agreement runs through Dec. 31, 2026, and may be terminated by either party with 10 days' notice.</p><p>Guhuan Medical has operated in the medical-product supply chain for more than a decade and holds stakes in over 30 medical cosmetic institutions, the filing said.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1227","symbol_name":"服装、服饰与奢侈品","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2588083699","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2588083699","pubTimestamp":1764644486,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Baijin Life Science  said its unit, Beijing Baijin Biotechnology, signed a cooperation framework agreement with Shanghai Guhuan Medical Equipment to support the expansion of its medical products business, according to a Monday Hong Kong bourse filing.Shares of the company were down nearly 2% in Tuesday morning trade.Under the framework, Beijing Baijin plans to invest in Guhuan Medical through an equity subscription and work with the company to develop branded medical product sales channels for Baijin's self-operated stores.The agreement runs through Dec. 31, 2026, and may be terminated by either party with 10 days' notice.Guhuan Medical has operated in the medical-product supply chain for more than a decade and holds stakes in over 30 medical cosmetic institutions, the filing said.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1227":"服装、服饰与奢侈品","01466":"佰金生命-八千"},"translate_title":"百金生命科学部门制定框架协议以发展医疗业务；股价下跌2%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01466":1},"content_text":"Baijin Life Science (HKG:1466) said its unit, Beijing Baijin Biotechnology, signed a cooperation framework agreement with Shanghai Guhuan Medical Equipment to support the expansion of its medical products business, according to a Monday Hong Kong bourse filing.Shares of the company were down nearly 2% in Tuesday morning trade.Under the framework, Beijing Baijin plans to invest in Guhuan Medical through an equity subscription and work with the company to develop branded medical product sales channels for Baijin's self-operated stores.The agreement runs through Dec. 31, 2026, and may be terminated by either party with 10 days' notice.Guhuan Medical has operated in the medical-product supply chain for more than a decade and holds stakes in over 30 medical cosmetic institutions, the filing said.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}